Medication info

S Jet Injection (Zinc Sulfate Heptahydrate)

Prescription medicationInjections
Ingredient · strength
Zinc Sulfate Hydrate›4.4mg / 1mL
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
A clear, colorless, and odorless liquid in a colorless and transparent vial injection.
Packaging
10 milliliters/vial [10mL × 10 vials], 15 milliliters/vial [15mL × 10 vials]
Approval status
Active

MFDS item code 201700041 · Notified 2017.01.03

Summary

Main use
Prevention of zinc deficiency during total parenteral nutrition (TPN)
Who uses it
Adults · Children
Adult dosage
Metabolically stable patients receiving TPN 2.5 ∼ 4 mg/day Adult patients with small intestinal fluid losses Additional 12.2 mg/L (volume of fluid lost) or Additional 17.1 mg/kg (amount excreted) Acute catabolic state 4.5 ∼ 6 mg/day Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment.
Children's dosage
Children 5 years of age and younger: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Prevention of zinc deficiency during total parenteral nutrition (TPN)

View approved original text

When administering total parenteral nutrition (TPN), zinc is an essential mineral for maintaining bodily functions and tissue recovery, so it must be supplemented adequately. Zinc supplementation helps enhance immunity and wound healing and supports normal growth and development. Therefore, during TPN, zinc supplementation is used to improve nutritional status and prevent complications.

Dosage and Administration

Adult dosage

Metabolically stable patients receiving TPN 2.5 ∼ 4 mg/day Adult patients with small intestinal fluid losses Additional 12.2 mg/L (volume of fluid lost) or Additional 17.1 mg/kg (amount excreted) Acute catabolic state 4.5 ∼ 6 mg/day Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment.

Children's dosage

Children 5 years of age and younger: 100 ug/kg/day Premature infants weighing 3 kg or less: 300 ug/kg/day

Precautions

This medication should not be administered directly into the peripheral vein without dilution. Administering it directly into the peripheral vein may increase the risk of phlebitis or kidney damage due to zinc. As the zinc content is very low, serious toxic symptoms due to this drug are very rare. When mixing this drug with TPN solution, it is advisable to work in a laminar flow environment to maintain sterility. Moreover, parenteral medications should be visually inspected for precipitate or discoloration prior to administration. When zinc is administered with copper, the serum copper levels may decrease, so regular monitoring of plasma copper and zinc levels should be conducted to inform dosing. This medication is excreted from the body through the intestines and kidneys, so patients with abnormalities in excretory organs should consider the possibility of zinc accumulation in the body. The safety of this drug has not been established in pregnant women or women who may become pregnant, therefore it should only be used cautiously when the benefits of treatment are judged to outweigh the risks. Zinc can cross the placenta and can be found in breast milk. In cases of overdose, symptoms such as nausea, vomiting, dehydration, electrolyte imbalances, dizziness, abdominal pain, drowsiness, and ataxia may occur, and in severe cases, it can be fatal. Calcium supplementation may help prevent the toxicity of zinc. This medication should be stored out of reach of children and kept in its original packaging in a dry place at room temperature. It does not contain preservatives, therefore any unused portion should be discarded.

Side effects

  • nausea
  • vomiting
  • dehydration
  • electrolyte imbalance
  • dizziness
  • abdominal pain
  • drowsiness
  • cooperative motor ataxia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture infiltration, and the storage temperature should be maintained between 1 degree Celsius and 30 degrees Celsius. Storing it this way will help preserve its efficacy.

Appearance and packaging

Appearance

A clear, colorless, and odorless liquid in a colorless and transparent vial injection.

Package unit

10 milliliters/vial [10mL × 10 vials], 15 milliliters/vial [15mL × 10 vials]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.